There was no significant difference in the median CD4+ cell counts between tumors from co-inoculation with YTN16 and LmcMF tumor (fibrous tumors) and those from inoculation with YTN16 alone (data not shown). This evidence concerns the gene CD4 and fibroblastic neoplasm.